HSBC downgraded AbbVie (ABBV) to Hold from Buy.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV:
- Nike reports Q1 beat, U.S. takes 5% stake in Lithium Americas: Morning Buzz
- Climb Bio appoints Altschuller as Chief Financial Officer
- Bristol Myers, Takeda, Astex to contribute data for AI tool, Reuters says
- AbbVie begins construction on $70M expansion to bioresearch center in MA
- Pfizer Stock (PFE) Climbs after Pricing Deal with Trump, 3-Year Exemption from Pharma Tariffs